Haytaian Peter D
Officer at ELV
- Sold, on record
- $67.4M
- Dollars the filings state
- Form 4 sales
- 21
- Latest Mar 4, 2024
- Form 144 notices
- 1
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- ELVElevance Health, Inc.Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale ELVPlan not statedOct 9, 2020 2020
Sold 1,167 shares at $295.00 ($344k)
Haytaian Peter D, EVP & President, Commercial
Sold 3% of holdings ($11.5M position)37,935 shares left0.2x usual sizeFiling
- 2 Form 4 sale ELVPlan not statedOct 15, 2020 +6 days
Sold 5,834 shares at $291.95 ($1.7M)
Haytaian Peter D, EVP & President, Commercial
Sold 13.7% of holdings ($12.4M position)36,768 shares left1.3x usual sizeFiling
- 3 Form 4 sale ELVPlan not statedNov 16, 2020 +32 days
Sold 5,834 shares at $333.64 ($1.9M)
Haytaian Peter D, EVP & President, Commercial
Sold 15.2% of holdings ($12.8M position)32,642 shares left1x usual sizeFiling
- 4 Form 4 sale ELVPlan not statedDec 15, 2020 +29 days
Sold 5,833 shares at $312.53 ($1.8M)
Haytaian Peter D, EVP & President, Commercial
Sold 15.2% of holdings ($12M position)32,642 shares left1x usual sizeFiling
- 5 Form 4 sale ELVUnusualMar 22, 2021 +97 days
Sold 59,500 shares at $349.20 ($20.8M)
Haytaian Peter D, EVP & President, Commercial
Sold 72.5% of holdings ($28.6M position)22,544 shares left10.2x usual sizeFiling
- 6 Form 4 sale ELVUnusualMar 10, 2022 +353 days
Sold 17,703 shares at $460.71 ($8.2M)
Haytaian Peter D, EVP & Pres., DBG & IngenioRx
Sold 59.3% of holdings ($13.8M position)12,161 shares left3x usual sizeFiling
- 7 Form 144 notice ELVNoticeMar 4, 2024 +725 days
Filed to sell 21,095 shares ($10.6M)
Haytaian Peter D, Officer
10b5-1 planFiling
- 8 Form 4 sale ELVRoutineMar 4, 2024 same day
Sold 21,095 shares at $500.18 ($10.6M)
Haytaian Peter D, EVP & Pres Carelon & CarelonRx
10b5-1 planSold 52.8% of holdings ($20M position)18,887 shares leftFollows a Form 144Filing
Every transaction
Loading transactions…
Sales and notices (22)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Mar 4, 2024 | Mar 5, 2024 | ELV | EVP & Pres Carelon & CarelonRx | Form 4 sale | 21,095 | $10.6M | 52.8% | Routine | SEC |
| Mar 4, 2024 | Mar 4, 2024 | ELV | Officer | Form 144 notice | 21,095 | $10.6M | Notice | SEC | |
| Mar 10, 2022 | Mar 14, 2022 | ELV | EVP & Pres., DBG & IngenioRx | Form 4 sale | 17,703 | $8.2M | 59.3% | Unusual | SEC |
| Mar 22, 2021 | Mar 23, 2021 | ELV | EVP & President, Commercial | Form 4 sale | 59,500 | $20.8M | 72.5% | Unusual | SEC |
| Dec 15, 2020 | Dec 17, 2020 | ELV | EVP & President, Commercial | Form 4 sale | 5,833 | $1.8M | 15.2% | Plan not stated | SEC |
| Nov 16, 2020 | Nov 18, 2020 | ELV | EVP & President, Commercial | Form 4 sale | 5,834 | $1.9M | 15.2% | Plan not stated | SEC |
| Oct 15, 2020 | Oct 19, 2020 | ELV | EVP & President, Commercial | Form 4 sale | 5,834 | $1.7M | 13.7% | Plan not stated | SEC |
| Oct 9, 2020 | Oct 13, 2020 | ELV | EVP & President, Commercial | Form 4 sale | 1,167 | $344k | 3.0% | Plan not stated | SEC |
| Oct 2, 2020 | Oct 6, 2020 | ELV | EVP & President, Commercial | Form 4 sale | 4,667 | $1.3M | 10.7% | Plan not stated | SEC |
| Jun 8, 2020 | Jun 10, 2020 | ELV | EVP & President, Commercial | Form 4 sale | 14,001 | $4.2M | 26.4% | Unusual | SEC |
| Dec 24, 2019 | Dec 26, 2019 | ELV | EVP & President, Commercial | Form 4 sale | 8,333 | $2.5M | 28.5% | Unusual | SEC |
| Nov 18, 2019 | Nov 20, 2019 | ELV | EVP & President, Commercial | Form 4 sale | 12,095 | $3.6M | 29.2% | Unusual | SEC |
| Oct 28, 2019 | Oct 30, 2019 | ELV | EVP & President, Commercial | Form 4 sale | 9,586 | $2.6M | 20.3% | Plan not stated | SEC |
| Dec 27, 2018 | Dec 28, 2018 | ELV | EVP & President, Commercial | Form 4 sale | 3,000 | $769k | 6.9% | Plan not stated | SEC |
| Nov 27, 2018 | Nov 29, 2018 | ELV | EVP & President, Commercial | Form 4 sale | 4,500 | $1.3M | 9.4% | Plan not stated | SEC |
| Oct 31, 2018 | May 7, 2021 | ELV | EVP & President, Commercial | Form 4 sale | 1,000 | $270k | 4.4% | Plan not stated | SEC |
| Oct 26, 2018 | Oct 30, 2018 | ELV | EVP & President, Commercial | Form 4 sale | 3,500 | $937k | 6.8% | Plan not stated | SEC |
| Sep 27, 2018 | Sep 28, 2018 | ELV | EVP & President, Commercial | Form 4 sale | 4,500 | $1.2M | 8.1% | Plan not stated | SEC |
| Sep 6, 2018 | Sep 7, 2018 | ELV | EVP & President, Commercial | Form 4 sale | 2,936 | $793k | 5.0% | Plan not stated | SEC |
| Aug 27, 2018 | Aug 29, 2018 | ELV | EVP & President, Commercial | Form 4 sale | 3,500 | $931k | 5.8% | Plan not stated | SEC |
| Dec 15, 2014 | Dec 17, 2014 | ELV | EVP & Pres., Govt. Bus. Div. | Form 4 sale | 649 | $80k | 1.7% | Plan not stated | SEC |
| Dec 8, 2014 | Dec 10, 2014 | ELV | EVP & Pres., Govt. Bus. Div. | Form 4 sale | 12,826 | $1.6M | 25.3% | Unusual | SEC |